Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Agente hemostático de colágeno absorbible con trombina

Número de PMA: P170012 · 2026-09-03

SolicitanteDilon Technologies, Inc.
Fecha de decisión2026-09-03
Número PMAP170012
Código de productoPMX
Clase del dispositivoClase 3
Especialidad médicaG
Número de regulación21 CFR 8
Comité asesorSU

Resumen del dispositivo

Absorbable collagen hemostatic agent with thrombin is the device name listed in this FDA 510(k) record. The listed applicant is Dilon Technologies, Inc.. It received FDA 510(k) clearance on 2026-09-03. The device is classified under product code PMX. It was reviewed by the SU advisory panel.

Preguntas frecuentes

What is the Absorbable collagen hemostatic agent with thrombin?

Absorbable collagen hemostatic agent with thrombin is a medical device that received FDA 510(k) clearance on 2026-09-03. The listed applicant is Dilon Technologies, Inc..

When did Absorbable collagen hemostatic agent with thrombin receive FDA 510(k) clearance?

The clearance date for Absorbable collagen hemostatic agent with thrombin can be found in the official FDA records.

Who is the listed applicant for Absorbable collagen hemostatic agent with thrombin?

The FDA 510(k) record lists Dilon Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Absorbable collagen hemostatic agent with thrombin?

The FDA product code for Absorbable collagen hemostatic agent with thrombin is PMX.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑